USANA Health Sciences (USNA) Tops Q4 EPS by 35c, offers guidance
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $21.72 +1.73%
EPS Growth %: -41.9%
Financial Fact:
Net earnings: 30.1M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: -41.9%
Financial Fact:
Net earnings: 30.1M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $0.87, $0.35 better than the analyst estimate of $0.52. Revenue for the quarter came in at $221 million versus the consensus estimate of $212.84 million.
GUIDANCE:
USANA Health Sciences sees FY2024 EPS of $2.40-$3.00, versus the consensus of $2.94. USANA Health Sciences sees FY2024 revenue of $850-920 million, versus the consensus of $912.3 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Biogen expects $164M R&D charge to hit Q2 2026 earnings
- NHC acquires 35 facilities from NHI for $560 million
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
